A well-studied, widely used class of drugs for heart health may have benefits for Huntington’s disease. A new paper ...

Vico Therapeutics have shared interim data about their drug, VO659, which targets the CAG expansion that causes several ...

In an update shared today, uniQure announced alignment with the US drug regulator on key criteria for accelerated approval of ...

A new Phase 1 clinical trial for the huntingtin-lowering drug ALN-HTT02 was initiated this week with the first dose given.

At this time of giving, we want to give thanks to you, the Huntington’s disease (HD) community, for all you have done for HD ...

In plain language. Written by scientists. For the global HD community.

Here, we cover a report on Advanced Care Planning (ACP) prepared by clinical researchers at the University College London, reminding us there are things that can be done right now to improve the lives ...